Following the report of success in performing the first ApoGraft based stem cell transplant procedure, the stock price of the Tel Aviv, Israel-based company jumped to more than double and hit a 52-week high of $13.50 per share. The stock
MUMBAI/NEW DELHI, June 14 (Reuters) - India’s Apollo Tyres Ltd lost a third of its market value over two days as investors fretted over the debt it will take on to fund its $2.5-billion acquisition of U.S.-based Cooper Tire & Rubber Co . …
An experiment that produced human eggs from stem cells could one day be a boon for women who are desperate to have a baby, according to a study published on Sunday. The work sweeps away the belief that a woman has only a limited …
KUSA - Jake Jackson, 14, knows a lot about pigs. From feeding to breeding, he's spent his whole life around the farm, first with horses, now with his pigs. Jake is attending the National Western Stock Show, competing in the hog …
9News8mon
NeoStem, Inc. (Nasdaq: NBS) announced that it has entered into a definitive agreement to acquire California Stem Cell, Inc. ("CSC"), an Irvine, California based stem cell biotechnology company. As a result of this acquisition, NeoStem …
Biotechnology company ReNeuron Group Plc said its experimental stem cell therapy helped some patients improve ... to 3.45 pence per share in morning trade on Monday on the London Stock Exchange. ReNueron's trial adds to a small but …
“We used to recommend the stock of StemCells Inc., which uses adult stem cells derived from organs, but while it has some patents, it still really hasn't done anything yet,” John McCamant, editor of the Medical Technology Stock Letter …
Stocks tumbled again Tuesday, despite efforts by the Federal Reserve to keep credit flowing to businesses and word from Fed Chairman Ben Bernanke that the central bank could soon cut interest rates to re-energize the economy. The Dow …
NEW YORK – Shares of Lumber Liquidators slumped 5 percent in volatile premarket trading Thursday before the company, which has been battered by reports of unsafe products, provides investors with an update about its business. Continue …
PITTSBURGH (CNNMoney.com) -- Companies that develop drugs using embryonic stem cell research could soon enter a bold ... The analysts interview for this story do not own stock in the companies mentioned here, and their firms have not …